Charles A. Reinhart III - Jun 6, 2023 Form 4 Insider Report for Pacira BioSciences, Inc. (PCRX)

Role
Chief Financial Officer
Signature
/s/ Kristen Williams, Attorney-in-Fact
Stock symbol
PCRX
Transactions as of
Jun 6, 2023
Transactions value $
-$100,106
Form type
4
Date filed
6/7/2023, 09:29 PM
Previous filing
Jun 8, 2022
Next filing
Jun 16, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PCRX Common Stock Sale -$48.2K -1.24K -3.41% $38.99 35K Jun 6, 2023 Direct F1
transaction PCRX Common Stock Sale -$51.9K -1.37K -3.92% $37.87 33.6K Jun 7, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units.